Change search
ReferencesLink to record
Permanent link

Direct link
Equal access to treatment? Population-based follow-up of drugs dispensed to patients after acute myocardial infarction in Sweden.
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine. Centre for Epidemiology, Swedish National Board of Health and Welfare, 106 30, Stockholm, Sweden .
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine. The Swedish Council on Technology Assessment in Health Care, Stockholm, Sweden .
2008 (English)In: European Journal of Clinical Pharmacology, ISSN 0031-6970, E-ISSN 1432-1041, Vol. 64, no 4, 417-424 p.Article in journal (Refereed) PublishedText
Abstract [en]

Background and Objective The establishment of national guidelines is one approach to creating equity in terms of access to care, and both internationally and in Sweden, guidelines have been developed for coronary heart disease. We have analysed drug treatment in Sweden according to national guidelines after acute myocardial infarction (AMI). The aim was to investigate whether there are differences between population groups according to sex, education, country of birth and diabetes.

Methods Information was obtained from the Swedish Prescribed Drug Register on drugs dispensed between July and October 2005 for incident cases of AMI during the period 2003-2004 (n=28,168). Data on socio-economic and demographic conditions were included. Dispensed drugs after AMI were compared to the recommended drug treatment according to Swedish and European guidelines - acetylsalicylic acid (ASA), beta-blockers, lipid-lowering drugs and angiotensin-converting enzyme inhibitors (ACE inhibitors).

Results We found that, in general, there were only small differences between the sexes and between educational groups. The greatest differences were found in comparisons between regions of birth. In particular, foreign-born patients resident in Sweden but originally from outside the EU25 countries used fewer drugs than Swedish-born patients. The OR (odds ratio) for ASA was 0.73 [95% confidence interval (CI) 0.63-0.85], for beta-blockers, 0.72 (0.63-0.83), for lipid-lowering drugs, 0.75 (0.65-0.86) and for ACE inhibitors, 0.76 (0.67-0.86).

Conclusions In general, we found only slight differences - or none at all - between population groups in terms of drug treatment after AMI. Only among immigrants from outside the EU25 countries was there a tendency towards a lesser use of the recommended drugs according to the national guidelines.

Place, publisher, year, edition, pages
Heidelberg: Springer Berlin/Heidelberg, 2008. Vol. 64, no 4, 417-424 p.
Keyword [en]
AMI, dispensed drugs, education, equity, ethnicity, prescription database
National Category
Social and Clinical Pharmacy Pharmacology and Toxicology
URN: urn:nbn:se:umu:diva-117504DOI: 10.1007/s00228-007-0425-yISI: 000253571000013OAI: diva2:908470
Available from: 2016-03-02 Created: 2016-03-01 Last updated: 2016-03-02Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Löfroth, EmilRosén, Måns
By organisation
Department of Public Health and Clinical Medicine
In the same journal
European Journal of Clinical Pharmacology
Social and Clinical PharmacyPharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 13 hits
ReferencesLink to record
Permanent link

Direct link